Filed: 5/15/2025ACC: 0001415889-25-013093
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $1.18B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$1.18B
Total AUM (reported)
125.61M
Total Shares
Allocation by class
COM$1.03B87.5%
COM NEW$121.97M10.4%
SPONSORED ADS$8.41M0.7%
CL A ORD SHS$7.72M0.7%
CLASS A ORD SHS$6.48M0.6%
ORD SHS$2.13M0.2%
Portfolio Concentration
Top 3$512.95M43.6%
4–10$381.19M32.4%
11–25$253.00M21.5%
Rest$28.10M2.4%
Top 3 weight
43.6%
Top 10 weight
76.1%
Voting Authority Distribution
Total shares with voting rights: 125.61M
Sole
Full voting authority
125.61M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$317.31M
27.00%
Sole
8.49M
Shared
0.00
None
0.00
METSERA INC
SOLEShares3.75M
TypeSH
Market value$102.09M
8.69%
Sole
3.75M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares12.76M
TypeSH
Market value$93.55M
7.96%
Sole
12.76M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares4.03M
TypeSH
Market value$79.24M
6.74%
Sole
4.03M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares6.70M
TypeSH
Market value$77.36M
6.58%
Sole
6.70M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$52.34M
4.45%
Sole
3.88M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares3.11M
TypeSH
Market value$48.87M
4.16%
Sole
3.11M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.69M
TypeSH
Market value$43.33M
3.69%
Sole
2.69M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares4.15M
TypeSH
Market value$42.56M
3.62%
Sole
4.15M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares989.99K
TypeSH
Market value$37.49M
3.19%
Sole
989.99K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.68M
TypeSH
Market value$34.05M
2.90%
Sole
5.68M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.74M
TypeSH
Market value$31.64M
2.69%
Sole
1.74M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$22.74M
1.93%
Sole
2.17M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares1.05M
TypeSH
Market value$22.65M
1.93%
Sole
1.05M
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares5.05M
TypeSH
Market value$22.61M
1.92%
Sole
5.05M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares16.22M
TypeSH
Market value$22.22M
1.89%
Sole
16.22M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares3.18M
TypeSH
Market value$17.76M
1.51%
Sole
3.18M
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares2.30M
TypeSH
Market value$14.05M
1.20%
Sole
2.30M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares2.46M
TypeSH
Market value$13.12M
1.12%
Sole
2.46M
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$10.45M
0.89%
Sole
1.38M
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares2.48M
TypeSH
Market value$9.18M
0.78%
Sole
2.48M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares3.26M
TypeSH
Market value$9.02M
0.77%
Sole
3.26M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares1.35M
TypeSH
Market value$8.41M
0.72%
Sole
1.35M
Shared
0.00
None
0.00
PERCEPTIVE CAP SOLUTIONS COR
SOLEShares750K
TypeSH
Market value$7.72M
0.66%
Sole
750K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares632.93K
TypeSH
Market value$7.38M
0.63%
Sole
632.93K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $317.31M 27.00% | 8.49M | 0.00 | 0.00 |
METSERA INCSOLE | COM | 3.75M | SH | $102.09M 8.69% | 3.75M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 12.76M | SH | $93.55M 7.96% | 12.76M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 4.03M | SH | $79.24M 6.74% | 4.03M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 6.70M | SH | $77.36M 6.58% | 6.70M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $52.34M 4.45% | 3.88M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 3.11M | SH | $48.87M 4.16% | 3.11M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.69M | SH | $43.33M 3.69% | 2.69M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 4.15M | SH | $42.56M 3.62% | 4.15M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 989.99K | SH | $37.49M 3.19% | 989.99K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 5.68M | SH | $34.05M 2.90% | 5.68M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1.74M | SH | $31.64M 2.69% | 1.74M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $22.74M 1.93% | 2.17M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 1.05M | SH | $22.65M 1.93% | 1.05M | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 5.05M | SH | $22.61M 1.92% | 5.05M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 16.22M | SH | $22.22M 1.89% | 16.22M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 3.18M | SH | $17.76M 1.51% | 3.18M | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 2.30M | SH | $14.05M 1.20% | 2.30M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 2.46M | SH | $13.12M 1.12% | 2.46M | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 1.38M | SH | $10.45M 0.89% | 1.38M | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 2.48M | SH | $9.18M 0.78% | 2.48M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 3.26M | SH | $9.02M 0.77% | 3.26M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.35M | SH | $8.41M 0.72% | 1.35M | 0.00 | 0.00 |
PERCEPTIVE CAP SOLUTIONS CORSOLE | CL A ORD SHS | 750K | SH | $7.72M 0.66% | 750K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 632.93K | SH | $7.38M 0.63% | 632.93K | 0.00 | 0.00 |
Page 1 of 2